Seaport Therapeutics, Inc. Common Stock (NASDAQ: SPTX) is a Healthcare company (Biotechnology) with a market capitalization of $973M. The Maz Rating grades it against the other companies in its sector.
Seaport Therapeutics, Inc. Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $18.17, Seaport Therapeutics, Inc. Common Stock trades at 2.4x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -59.1%, return on invested capital of -37.5% and a free cash flow yield of -9.8%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 17.48. Over the past 52 weeks the share price ranged from $14.85 to $28.38, with a beta of 1.13.
Seaport Therapeutics, Inc. Common Stock does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.